This application seeks to develop and apply new small molecule strategies that go beyond fluorescent proteins to image protein function and discrete RNAs in vitro or inside the cell and create tools that impact discovery in biology and medicine. One tool is based on bipartite tetracysteine (C4) display, in which the linear C4 binding site for a biarsenical dye is split between two approximated regions of a folded protein or two members of a protein partnership. During the first funding period we reported that the linear tetracysteine (C4) sequence preferred by biarsenicals FlAsH and ReAsH could be split between two members of a protein partnership or two approximated regions of a protein while maintaining high affinity and brightness. Subsequently we explored the structural requirements of bipartite C4 display, and applied it to generate prototypes for encodable, fluorescent protein-free kinase sensors and p53 rescue agent sensors, as well as a strategy for the selective imaging of protein-protein complexes by electron microscopy. This renewal requests support for the continued development and application of bipartite tetracysteine display as well as a newly discovered orthogonal labeling strategy based on pro-fluorescent bis-boronic acids. We seek to achieve three major goals.
The first (Aim 1) is a deeper, quantitative understanding of bipartite C4 display obtained through detailed kinetic, thermodynamic, structural, and photophysical experiments. We believe that the information obtained therein will inform and improve our ability to navigate and interpret the remaining experiments in this application and greatly facilitate the design of new bipartite-based experiments and sensors. The experiments in Aim 2 continue two projects from the previous funding period that possess the greatest potential impact.
In Aim 2. 1 we continue to develop encodable tyrosine kinase sensors based on bipartite C4 display, and apply them in collaboration to explore how Abl kinases coordinate cytoskeletal rearrangements in response to growth factors and adhesive cues.
In Aim 2. 2 we continue to develop sensors for molecules that stabilize oncogenic p53 variants, and applying them to identify new p53 small molecule chaperones. The experiments in Aim 3 explore the potential of bis-boronic acids as non-toxic, non-redox alternatives to biarsenicals for live cell imaging. We will evaluate a set of cyanine-based bis-boronic acids as brighter, more versatile alternatives for labeling serine-rich protein motifs, applying validated selection methods to identify optimal sequence tags. We will then build on these results to develop encodable RNA tags, and apply them in collaboration to visualize the mobility of Group II introns and trafficking of the hepatitis C virus RNA genome.
This proposal requests continued support to develop and apply bipartite tetracysteine display, and a novel orthogonal small molecule labeling strategy, to fluorescently image discrete protein conformations and protein assemblies in live cells. Detailed kinetic, thermodynamic, and photo-physical experiments will place the methodology on firm biophysical footing. Carefully chosen biological collaborations will showcase utility through applications to monitor Abl kinase, rescue destabilized p53, and monitor trafficking of the hepatitis C viral genome.
|Bottanelli, Francesca; Kromann, Emil B; Allgeyer, Edward S et al. (2016) Two-colour live-cell nanoscale imaging of intracellular targets. Nat Commun 7:10778|
|Doerner, Amy; Scheck, Rebecca; Schepartz, Alanna (2015) Growth Factor Identity Is Encoded by Discrete Coiled-Coil Rotamers in the EGFR Juxtamembrane Region. Chem Biol 22:776-84|
|Lowder, Melissa A; Doerner, Amy E; Schepartz, Alanna (2015) Structural Differences between Wild-Type and Double Mutant EGFR Modulated by Third-Generation Kinase Inhibitors. J Am Chem Soc 137:6456-9|
|Alexander, Seth C; Schepartz, Alanna (2014) Interactions of AsCy3 with cysteine-rich peptides. Org Lett 16:3824-7|
|Sinclair, Julie K-L; Schepartz, Alanna (2014) Influence of macrocyclization on allosteric, juxtamembrane-derived, stapled peptide inhibitors of the epidermal growth factor receptor (EGFR). Org Lett 16:4916-9|
|Sinclair, Julie K-L; Denton, Elizabeth V; Schepartz, Alanna (2014) Inhibiting epidermal growth factor receptor at a distance. J Am Chem Soc 136:11232-5|
|Erdmann, Roman S; Takakura, Hideo; Thompson, Alexander D et al. (2014) Super-resolution imaging of the Golgi in live cells with a bioorthogonal ceramide probe. Angew Chem Int Ed Engl 53:10242-6|
|Hobert, Elissa M; Doerner, Amy E; Walker, Allison S et al. (2013) Effective molarity redux: Proximity as a guiding force in chemistry and biology. Isr J Chem 53:567-576|
|Scheck, Rebecca A; Lowder, Melissa A; Appelbaum, Jacob S et al. (2012) Bipartite tetracysteine display reveals allosteric control of ligand-specific EGFR activation. ACS Chem Biol 7:1367-76|
|Lowder, Melissa A; Appelbaum, Jacob S; Hobert, Elissa M et al. (2011) Visualizing protein partnerships in living cells and organisms. Curr Opin Chem Biol 15:781-8|
Showing the most recent 10 out of 16 publications